Reliable Drug of Abuse (DOA) Screening Solutions: Partnering for Global Public Safety and HealthIn an era where public safety and workplace compliance are top priorities, the demand for rapid, accurate, and cost-effective Drug of Abuse (DOA) screening is higher than ever. From roadside checks to reh

Say goodbye to embarrassment and hassle: Why is the Bioteke saliva pregnancy test a new option for women to test for pregnancy?

Cervical cancer remains one of the most preventable malignancies through evidence-based screening programs. With advances in molecular diagnostics, screening strategies have evolved from cytology-based approaches to HPV testing–centered models.
According to the American Cancer Society (ACS) Cervical Cancer Screening Guidelines, HPV testing is the preferred primary screening method for average-risk individuals with a cervix. This article provides a professional interpretation of the latest guidelines, with a focus on HPV testing, screening intervals, and clinical implementation.

Cervical cancer is the fourth most common cancer in women worldwide, with approximately 660,000 new cases and 350,000 deaths in 2022.Screening, diagnosis and treatment of cervical cancer have become a common problem in global health today. Bioteke provides innovative and effective HPV screening and diagnosis solutions for this purpose.

Drug abuse screening has become an essential tool across law enforcement, workplace safety, public health, and clinical emergency settings. To meet the demand for fast, accurate, and user-friendly testing solutions, Bioteke has launched the Multi-Drug Urine Test, available in both panel and cup formats. Designed with high sensitivity, flexible cut-off levels, and customizable 2–14 drug combinations, this rapid test offers a dependable solution for modern drug detection needs.